A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03192748

Enrollment

3000

Registered

2017-06-20

Start date

2017-06-19

Completion date

2019-06-30

Last updated

2017-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eczema

Brief summary

The purpose of this study is get to know what and how Runzaozhiyang capsule in hospital results in drug-induced liver injury or adverse drug reactions from a cohort event monitoring as registration research.

Detailed description

In order to improving monitoring drug-induced liver injury or adverse drug reactions of Chinese medicine containing Radix Polygoni Multiflori in clinical real world, registry study is suitable method in this area. Otherwise, nested case control study is used to find out the mechanism of drug-induced liver injury. Calculate the incidence of drug-induced liver injury or adverse drug reactions is one of the main aims for this study. Safety surveillance on Chinese medicine containing Radix Polygoni Multiflori is an important problem that needs to be sorted out through large sample observational study. According to the relevant regulations of the CFDA, 3000 cases need to be registered at least. The aim population is who using Runzaozhiyang capsule 's with abnormal liver function before medication from June 2017 to June 2019.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Hours to No maximum

Healthy volunteers

Inclusion criteria

Patients using Runzaozhiyang capsule 's with abnormal liver function before medication from June 2017 to June 2019.

Exclusion criteria

none

Design outcomes

Primary

Measure	Time frame	Description
Is there any abnormality in liver function test index（ALT、AST、TBil、GGT） after using runzaozhiyang capsule around two weeks later?	After using runzaozhiyang capsule around two weeks later.	Based on data from the National Center for adverse drug reactions (ADR), Chinese herbal medicine containing Polygonum multiflorum may cause liver damage, but further confirmation is needed.The liver function includes glutamic-pyruvic transaminase,glutamic-oxalacetic transaminase,GGT,TBil.

Secondary

Measure	Time frame	Description
Is there any abnormality in renal function test index（Bun、Cr） after medication?	After using runzaozhiyang capsule around two weeks later.	Observation of whether the kidney function damage after treatment.The renal function includes creatinine,usea nitrogen.
Is there any abnormality in ECG after medication?	After using runzaozhiyang capsule around two weeks later.	Observation of whether the ECG damage after treatment.ECG is the most common method of detection of myocardial ischemia and the diagnosis of angina pectoris.
Is there any abnormality in basic life sign（body temperature, blood pressure and pulse）？	During using runzaozhiyang capsule around two weeks.	Observation of whether the basic life sign damage after treatment.In the medical care system, body temperature, blood pressure and pulse are the most important and basic three physiological parameters of the vital signs.

Contacts

Primary ContactYanming Xie, BA

datamining5288@163.com86-13911112416

Backup ContactLianxin Wang, doctor

wanglianxin_tcm@126.com86-13521781839

Outcome results